senolytic therapy
Longevity Science Unlocks MicroRNA‑217 Power
Longevity Science Unlocks MicroRNA-217 Power MicroRNA-217 inhibition can slow pancreatic aging, improve glucose handling, and potentially extend healthy lifespan. In 2023, researchers reported an 18% improvement in glucose tolerance when microRNA-217 inhibitors were given to aged mice for eight weeks. The study also noted a drop in circulating pro-inflammatory cytokines,